Cytoskeletal integrity as a drug target

Area of Science:

• Cell Biology
• Neuroscience
• Biochemistry

Background:

• The cytoskeleton, particularly microtubules (MTs), plays a vital role in cellular structure, protein localization, and intracellular transport.
• While traditionally studied for structural functions, the cytoskeleton's involvement in cell signaling, including signal transduction from the plasma membrane to the nucleus, is increasingly recognized.
• Neurofibrillary tangles (NFTs) in Alzheimer's disease (AD) are composed of the microtubule-associated protein tau, and amyloid peptides in AD can induce tau hyper-phosphorylation and cytoskeletal damage, implicating MT disruption in neurodegeneration.

Purpose of the Study:

• To test the hypothesis that drugs interacting with MTs can protect neurons against amyloid-beta (Abeta) toxicity by modulating early signaling events.
• To investigate the role of the cytoskeletal network as a sensor and transducer of cellular stress signals in neurons.

Main Methods:

• Utilized neuronal cell cultures challenged with various toxic stimuli.
• Administered low concentrations of compounds designed to stabilize MTs.
• Assessed the protective effects of these compounds against cytoskeletal disruption and neuritic dystrophy.

Main Results:

• Low concentrations of MT-stabilizing compounds demonstrated a protective effect on post-mitotic neurons against toxic stimuli.
• These agents successfully protected against the disruption of the cytoskeleton and neuritic dystrophy in neuronal cell cultures.

Conclusions:

• The cytoskeletal network functions as a critical sensor and transducer of neuronal stress signals.
• Modulating early signaling events through MT stabilization offers a promising therapeutic strategy for neurodegenerative conditions.
• Further development of agents that protect cytoskeletal integrity and cross the blood-brain barrier is necessary for in vivo applications in animal models.